Litigation Details for Humana Inc. v. Teva Pharmaceuticals USA Inc. (N.D. Cal. 2021)

✉ Email this page to a colleague

Docket	⤷ Sign Up	Date Filed	2021-12-12
Court	District Court, N.D. California	Date Terminated
Cause	15:1 Antitrust Litigation	Assigned To	Edward Milton Chen
Jury Demand		Referred To
Patents	6,043,230; 6,639,071; 6,642,245; 6,703,396; 6,939,964
Link to Docket	External link to docket

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .

The biologic drug covered by the patents cited in this case is ⤷ Sign Up .

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
2021-12-13	1	Complaint	and 6,043,230 (“the ’230 patent”) — all derived from the same patent application and 17 cover the … the patents — U.S. Patents Nos. 5,922,695 (“the ’695 patent”), 5,977,089 (“the ’089 16 patent”), and…infringing U.S. Patent Nos. 6,639,071 (the “’071 patent”) and 25 6,939,964 (the “’964 patent”). BMS was …include U.S. Patent Nos. 6,642,245 (“the ’245 patent”) and 6,703,396 (“the ’396 6 patent”). The FTC …Emory’s patents (the ’639, ’245, and ’396 patents), along with 22 Emory’s related U.S. Patent No. 5,	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document